Keywords: invitrogen, buy, zymed, 60m, corp, entered, into

Invitrogen to buy Zymed for $60M

Article | 17 January 2005

Invitrogen Corp has entered into a definitive agreement to acquire fellow US firm Zymed Laboratories, a privately-held antibody manufacturer, in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Drug Discovery

Go to company listing